✦ LIBER ✦

Regarding diarrhea in liver transplant recipients: Etiology and management.

✍ Scribed by I. Stelzmueller; M. Biebl; I. Graziadei; S. Wiesmayr; R. Margreiter; H. Bonatti

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 48 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20665

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diarrhea in liver transplant recipients:

Diarrhea in liver transplant recipients: Etiology and management

✍ Philip M. Ginsburg; Paul J. Thuluvath 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

Diarrhea is common after liver transplantation (LT). The true incidence of diarrhea in liver transplant recipients is unknown but possibly ranges from 10% to 43% based on a few published studies in other solid organ and bone marrow transplantation. Infectious etiologies, including cytomegalovirus (C

Post-liver-transplant anemia: Etiology a

Post-liver-transplant anemia: Etiology and management

✍ Anurag Maheshwari; Rajnish Mishra; Paul J. Thuluvath 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

Anemia is common after liver transplantation, with the incidence ranging from 4.3% to 28.2% depending on the criteria used to define anemia. The cause of anemia is unidentified in the majority of patients, and it is likely to be multifactorial. Immunosuppressive-medication-induced bone marrow suppre

Management of splenic artery aneurysms i

Management of splenic artery aneurysms in liver transplant recipients

✍ Mikel Gastaca; Alberto Ventoso; Andrés Valdivieso; Jorge Ortiz de Urbina 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

We read with great interest the recent article 1 describing Moon et al.'s experience with splenic artery aneurysms (SAAs) in adult living donor liver transplant recipients. The authors retrospectively reviewed 44 liver transplant recipients with SAAs out of 310 patients. Interestingly, portosystemic

Adherence in liver transplant recipients

✍ Patrizia Burra; Giacomo Germani; Francesca Gnoato; Silvia Lazzaro; Francesco Pao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Adherence to a medical regimen has been defined as the extent to which a patient's behavior coincides with clinical prescriptions. In liver transplant patients, adherence to immunosuppressive therapy and to medical indications in general is crucial for short-and long-term outcomes. Nonadherence to i

Antifungal prophylaxis in liver transpla

Antifungal prophylaxis in liver transplant recipients

✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse

Hepatitis B in liver transplant recipien

Hepatitis B in liver transplant recipients

✍ Robert G. Gish; Timothy McCashland 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire